These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 15580399

  • 1. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
    Tamori A, Nishiguchi S, Nishikawa M, Kubo S, Koh N, Hirohashi K, Shiomi S, Inoue M.
    J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
    [Abstract] [Full Text] [Related]

  • 2. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
    Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH.
    Mutat Res; 2004 Mar 22; 547(1-2):71-8. PubMed ID: 15013701
    [Abstract] [Full Text] [Related]

  • 3. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.
    Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E, Inoue M.
    Cancer Res; 2001 Mar 01; 61(5):1843-5. PubMed ID: 11280735
    [Abstract] [Full Text] [Related]

  • 4. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.
    Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T, Nakao A.
    Clin Cancer Res; 2002 Sep 01; 8(9):2875-8. PubMed ID: 12231530
    [Abstract] [Full Text] [Related]

  • 5. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.
    Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D.
    Clin Cancer Res; 2002 Feb 01; 8(2):481-7. PubMed ID: 11839667
    [Abstract] [Full Text] [Related]

  • 6. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y, Nishiguchi S, Tamori A, Koh N, Yano Y, Kubo S, Hirohashi K, Otani S.
    Clin Cancer Res; 2001 May 01; 7(5):1293-8. PubMed ID: 11350897
    [Abstract] [Full Text] [Related]

  • 7. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
    Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, Kanazumi N, Nakao A.
    Eur J Surg Oncol; 2006 Apr 01; 32(3):303-7. PubMed ID: 16478656
    [Abstract] [Full Text] [Related]

  • 8. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T, Nakao K.
    J Gastroenterol; 2004 Apr 01; 39(4):355-61. PubMed ID: 15168247
    [Abstract] [Full Text] [Related]

  • 9. Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection.
    Hayashi T, Tamori A, Nishikawa M, Morikawa H, Enomoto M, Sakaguchi H, Habu D, Kawada N, Kubo S, Nishiguchi S, Shiomi S.
    Liver Int; 2009 Jan 01; 29(1):126-32. PubMed ID: 18492017
    [Abstract] [Full Text] [Related]

  • 10. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.
    Hsia CC, Nakashima Y, Thorgeirsson SS, Harris CC, Minemura M, Momosaki S, Wang NJ, Tabor E.
    Oncol Rep; 2000 Jan 01; 7(2):353-6. PubMed ID: 10671685
    [Abstract] [Full Text] [Related]

  • 11. Somatic mutations of mitochondrial genome in hepatocellular carcinoma.
    Yin PH, Wu CC, Lin JC, Chi CW, Wei YH, Lee HC.
    Mitochondrion; 2010 Mar 01; 10(2):174-82. PubMed ID: 20006738
    [Abstract] [Full Text] [Related]

  • 12. p53 gene mutation spectrum in hepatocellular carcinoma.
    Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S.
    Cancer Res; 1992 Nov 15; 52(22):6358-64. PubMed ID: 1330291
    [Abstract] [Full Text] [Related]

  • 13. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
    Wu MY, Kuo CS, Lin CY, Lu CL, Syu Huang RF.
    Br J Nutr; 2009 Sep 15; 102(5):715-21. PubMed ID: 19331700
    [Abstract] [Full Text] [Related]

  • 14. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.
    Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K.
    Hepatology; 1995 Dec 15; 22(6):1702-7. PubMed ID: 7489977
    [Abstract] [Full Text] [Related]

  • 15. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
    Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER.
    Carcinogenesis; 2005 Jan 15; 26(1):145-52. PubMed ID: 15375011
    [Abstract] [Full Text] [Related]

  • 16. A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer.
    Prior SL, Griffiths AP, Lewis PD.
    Br J Dermatol; 2009 Nov 15; 161(5):1067-71. PubMed ID: 19624548
    [Abstract] [Full Text] [Related]

  • 17. [Aberrations of tumor suppressor genes in hepatocellular carcinomas].
    Fujimoto Y.
    Hokkaido Igaku Zasshi; 1994 Sep 15; 69(5):1252-60. PubMed ID: 7868063
    [Abstract] [Full Text] [Related]

  • 18. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
    Narimatsu T, Tamori A, Koh N, Kubo S, Hirohashi K, Yano Y, Arakawa T, Otani S, Nishiguchi S.
    Intervirology; 2004 Sep 15; 47(1):26-31. PubMed ID: 15044833
    [Abstract] [Full Text] [Related]

  • 19. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
    Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H, Hirohashi S.
    Hepatology; 1999 Mar 15; 29(3):703-9. PubMed ID: 10051471
    [Abstract] [Full Text] [Related]

  • 20. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W, Lu Q, Pan G.
    Zhonghua Wai Ke Za Zhi; 1998 Sep 15; 36(9):531-2. PubMed ID: 11825456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.